FDA.reportPublic FDA data

pirtobrutinib 100 MG Oral Tablet [Jaypirca]

RxCUI
2629349
RxNorm name
pirtobrutinib 100 MG Oral Tablet [Jaypirca]
Display name
pirtobrutinib 100 MG Oral Tablet [Jaypirca]
Full name
pirtobrutinib 100 MG Oral Tablet [Jaypirca]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JAYPIRCAPIRTOBRUTINIBEli Lilly and Companybd551845-0878-49a4-860f-839b83f6b8012026-03-06Warnings, Adverse reactionsExact identifier
rxcui: 2629349

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bd551845-0878-49a4-860f-839b83f6b801Jaypirca 100 MG Oral Tablet [PSN] · pirtobrutinib 100 MG Oral Tablet [Jaypirca] [SBD] · Jaypirca 100 MG Oral Tablet [SY]314These highlights do not include all the information needed to use JAYPIRCA safely and effectively. See full prescribing information for JAYPIRCA. JAYPIRCA ® (pirtobrutinib) tablets, for oral use Initial U.S. Approval: 202320260306